Hepatitis-B vaccine makers look abroad
With the domestic Hepatitis B vaccine market in a slump, pharma majors are looking overseas to shore up bottomlines. Wockhardt and Shantha Biotech are taking a lead in tapping foreign markets. While
With the domestic Hepatitis B vaccine market in a slump, pharma majors are looking overseas to shore up bottomlines. Wockhardt and Shantha Biotech are taking a lead in tapping foreign markets. While